United States Woundcare Management Medical Equipment Industry Report

Published by: Global Markets Direct

Published: Apr. 23, 2008 - 307 Pages

Table of Contents

1 Table Of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Definitions

2.2.1 Wound Care Management

2.2.1.1 Traditional Wound Management

2.2.1.2 Advanced Wound Management

2.2.1.3 Wound Closure Devices

2.2.1.4 Ostomy

2.2.1.5 Compression Therapy

3 Healthcare Sector Review

3.1 Healthcare Expenditure

3.2 Healthcare Infrastructure

3.2.1 Healthcare Personnel Data

3.2.2 Healthcare Facilities Data

4 Wound Care Mangement in United States

4.1 Wound Care Management Overall Revenues (2000-2012)

4.2 Wound Care Management Overall Volume (2000-2012)

4.3 Wound Care Management Overall Company Shares (2005-2006)

5 Wound Closure Devices in United States

5.1 Wound Closure Devices Overall Revenues (2000-2012)

5.1.1 Skin Closure Devices Overall Revenues (2000-2012)

5.1.2 Hemostats Overall Revenues (2000-2012)

5.1.3 Tissue Sealants Overall Revenues (2000-2012)

5.2 Wound Closure Devices Overall Volume (2000-2012)

5.2.1 Skin Closure Devices Overall Volume (2000-2012)

5.2.2 Hemostats Overall Volume (2000-2012)

5.2.3 Tissue Sealants Overall Volume (2000-2012)

5.3 Wound Closure Devices Average Price (2000-2012)

5.3.1 Hemostats Average Price (2000-2012)

5.3.2 Tissue Sealants Average Price (2000-2012)

5.3.3 Skin Closure Devices Average Price (2000-2012)

5.4 Wound Closure Devices Distribution Share

5.5 Wound Closure Devices Company Share

6 Ostomy in United States

6.1 Ostomy Overall revenues (2000-2012)

6.2 Ostomy Category Overall Volume (2000-2012)

6.3 Ostomy Average Price (2000-2012)

6.4 Ostomy Distribution Share (2005-2006)

6.5 Ostomy Company Share (2005-2006)

7 Advanced Wound Management in United States

7.1 Advanced Wound Management Revenue (2000-2012)

7.2 Advanced Wound Management Overall Volume (2000-2012)

7.3 Advanced Wound Management Average Price (2000-2012)

7.4 Advanced Wound Management Distribution Share (2005-2006)

7.5 Advanced Wound Management Company Share (2005-2006)

8 Traditional Wound Management in United States

8.1 Traditional Wound Management Overall Revenue (2000-2012)

8.2 Traditional Wound Management Overall Volume (2000-2012)

8.3 Traditional Wound Management Average Price (2000-2012)

8.4 Traditional Wound Management Distribution Share (2005-2006)

8.5 Traditional Wound Management Company Share (2005-2006)

9 Compression Therapy in United States

9.1 Compression Therapy Category Revenue (2000-2012)

9.2 Compression Therapy Category Volume (2000-2012)

9.3 Compression Therapy Average Price (2000-2012)

9.4 Compression Therapy Distribution Share (2005-2006)

9.5 Compression Therapy Company Share (2005-2006)

10 Baxter International Company Profile

10.1 Company Overview

10.2 Business Overview

10.2.1 BioScience

10.2.2 Medication Delivery

10.2.3 Renal

10.2.4 Products

10.2.5 History

10.3 Value Chain Analysis

10.3.1 Manufacturing

10.3.2 Product Development

10.3.3 Sales and Marketing

10.4 SWOT Analysis

10.4.1 Baxter International Inc. Strengths

10.4.2 Baxter International Inc. Weaknesses

10.4.3 Baxter International Inc. Opportunities

10.4.4 Baxter International Inc. Threats

10.5 Financial and Operational Review

10.6 Locations And Subsidiaries

10.7 Financial Deals Landscape

10.7.1 Baiyunshan And Baxter Form A Joint Venture In China

10.7.2 Baxter Signs Licensing Agreement With Intercytex And Spinal Restoration

10.7.3 Baxter Sells Transfusion Therapies Business to Texas Pacific and Maverick Capital

10.7.4 B. Braun Acquires Renal Therapy Business Of Baxter

10.7.5 Innovata signs a license agreement with Baxter International

10.7.6 Kuros Biosurgery Signs An Agreement With Baxter International

10.7.7 Gambro Signs An Agreement With Baxter

10.7.8 Baxter Healthcare And Gambro Enter Into An Agreement

10.7.9 Baxter and Cerus Enter Into Agreement With BioOne for Commercialization Of INTERCEPT Blood System

10.7.10 Baxter International And Kaketsuken Enter Into Agreement

10.7.11 Baxter To Acquire 40% Stake In Shanghai Baxter From Worldbest Treeful

10.8 Recent Developments

10.8.1 Jan 24, 2008: Baxter Achieves Record Sales and Earnings for Full-Year 2007

10.8.2 Dec 18, 2007: Baxter Elects CFO

10.8.3 Nov 13, 2007: Baxter Declares Quarterly Dividend

10.8.4 Aug 01, 2007: Baxter Elects New Board Director

10.8.5 Jul 31, 2007: Baxter Announces Quarterly Dividend

10.8.6 Mar 13, 2007: Baxter Declares Additional Share Repurchase Authorization

10.8.7 Feb 13, 2007: Baxter Announces Quarterly Dividend

10.8.8 Nov 28, 2006: Baxter Announces Annual Dividend

10.8.9 Sep 14, 2006: Baxter Appoints President, Baxter Latin America

10.9 Baxter International Inc. Pipeline Products

10.9.1 Next-Generation Home Hemodialysis Machine

10.9.1.1 Product Overview

10.9.1.2 Product Description

10.9.1.3 Product Status

10.9.1.4 Product Milestone

11 Covidien Ltd./Tyco Healthcare Company Profile

11.1 Company Overview

11.2 Business Overview

11.2.1 Imaging Solutions

11.2.2 Medical Devices

11.2.3 Medical Supplies

11.2.4 Pharmaceutical Products

11.2.5 Retail Products

11.2.6 Products

11.2.7 History

11.3 Value Chain Analysis

11.3.2 Product Development

11.3.3 Sales and Marketing

11.4 SWOT Analysis

11.4.1 Covidien Ltd./Tyco Healthcare Strengths

11.4.2 Covidien Ltd./Tyco Healthcare Weaknesses

11.4.3 Covidien Ltd./Tyco Healthcare Opportunities

11.4.4 Covidien Ltd./Tyco Healthcare Threats

11.5 Financial and Operational Review

11.5.1 Financial Statements

11.5.2 Financial Ratios

11.6 Locations And Subsidiaries

11.7 Financial Deals Landscape

11.7.1 Covidien Signs An Agreement With Allergan

11.7.2 Covidien Acquires Scandius Biomedical

11.7.3 Covidien International Finance Completes Private Placement Of $2,750 Million

11.7.4 Covidien And BioSynthema Enter Into Licensing Agreement

11.7.5 Integra LifeSciences Acquires Assets Of Radionics Division From Covidien

11.7.6 Covidien To Sell European Incontinence Business

11.7.7 Covidien To Acquire Tissue Science Laboratories

11.8 Recent Developments

11.8.1 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007

11.8.2 Mar 18, 2008: Covidien Declares Quarterly Dividend

11.8.3 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case

11.8.4 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results

11.8.5 Jan 15, 2008: Covidien Declares Quarterly Dividend

11.8.6 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results

11.8.7 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results

11.8.8 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent

11.8.9 Sep 28, 2007: Covidien Declares Quarterly Dividend

11.8.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results

11.9 Covidien Ltd./Tyco Healthcare Pipeline Products

11.9.1 PleuraSeal Lung Sealant System

11.9.1.1 Product Overview

11.9.1.2 Product Description

11.9.1.3 Product Status

11.9.1.4 Product Milestone

11.9.2 Sandman Intro CPAP Device

11.9.2.1 Product Overview

11.9.2.2 Product Description

11.9.2.3 Product Status

11.9.2.4 Product Milestone

12 3M Company Profile

12.1 Company Overview

12.2 Business Overview

12.2.1 Consumer and Office

12.2.2 Display and Graphics

12.2.3 Electro and Communications

12.2.4 Health Care

12.2.5 Industrial and Transportation

12.2.6 Safety, Security and Protection Services

12.2.7 Products

12.3 Value Chain Analysis

12.3.1 Manufacturing

12.3.2 Product Development

12.3.3 Sales and Marketing

12.4 SWOT Analysis

12.4.1 3M Company Strengths

12.4.2 3M Company Weaknesses

12.4.3 3M Company Opportunities

12.4.4 3M Company Threats

12.5 Financial and Operational Review

12.6 Locations And Subsidiaries

12.6.1 Other Locations & Subsidiaries

12.7 Financial Deals Landscape

12.7.1 3M Canada Acquires Les Entreprises Solumed

12.7.2 3M Acquires Bondo

12.7.3 3M Acquires Lingualcare

12.7.4 3M Acquires Abzil Industria E Comercio

12.7.5 3M Acquires Neo Plast

12.7.6 3M Acquires Assets Of DMS Chile

12.7.7 3M Acquires Business Of Innovative Paper Technologies

12.7.8 3M Acquires Powell

12.7.9 Gen-Probe Signs An Agreement With 3M Company

12.7.10 3M Acquires Acolyte Biomedica

12.7.11 3M Acquires Sealed Air Corp.'S Interest In Polymask Corp

12.7.12 3M Sells Its Pharmaceutical Business To Meda AB

12.7.13 3M Acquires SoftMed Systems

12.7.14 3M Sells its Pharmaceuticals Business to Graceway

12.7.15 Gen-Probe Signs An Agreement With 3M

12.7.16 3M Sells its Pharmaceutical Operations in the Asia Pacific Region to Ironbridge Capital and Archer Capital

12.7.17 3M Acquires Biotrace International

12.7.18 Ekahau Secures $16 Million In Additional Funding

12.7.19 3M Acquires Brontes Technologies

12.7.20 3M acquires Nylonge Corp

12.7.21 3M Signs An Agreement With ClozeX Medical

12.7.22 3M Acquires OMNII Oral Pharmaceuticals

12.7.23 3M Sells Pharmaceutical Operations In The United States To Graceway

12.7.24 3M Sells Pharmaceutical Business In Europe To Meda AB

12.7.25 3M Sells Pharmaceutical Operations In The Asia Pacific To Ironbridge and Archer Capital .. 231

12.7.26 3M Acquires Accuspray Application Technologies Inc.

12.7.27 3M to acquire Rochford Thompson Equipment

12.7.28 3M To Acquire Aearo Technologies From Permira

12.7.29 Permira To Sell Aearo Technologies To 3M

12.8 Recent Developments

12.8.1 Mar 31, 2008: HighJump Software Introduces Survey Management Solution for Direct Store Delivery Businesses

12.8.2 Mar 24, 2008: Brazil's Companhia de Transmissao de Energia Eletrica Paulista Chooses 3M ACCR for Upgrade of Line Over Parana River in Sao Paulo State

12.8.3 Mar 19, 2008: 3M to Headquarter Optical Systems Business in Asia

12.8.4 Mar 19, 2008: 3M To Headquarter Optical Systems Business In North Asia

12.8.5 Feb 11, 2008: 3M Increases Dividend for the 50th Straight Year

12.8.6 Nov 12, 2007: 3M Declares Quarterly Dividend

12.8.7 Oct 24, 2007: 3M And Sanyo Settle Suit On Lithium Ion Battery

12.8.8 Aug 13, 2007: 3M Declares Quarterly Dividend

12.8.9 May 08, 2007: 3M Declares Quarterly Dividend

12.8.10 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop Rapid Molecular Tests

13 Ethicon, Inc. Company Profile

13.1 Company Overview

13.2 Business Overview

13.2.1 Products

13.3 Locations And Subsidiaries

13.4 Financial Deals Landscape

13.4.1 Edwards Lifesciences Acquires CardioVations Product Line From ETHICON

13.4.2 Musculoskeletal Transplant Signs Marketing Agreement With ETHICON

13.4.3 ETHICON Acquires Vascular Control Systems

13.4.4 Datascope Acquires Endoscopic Vessel Harvesting Business From ETHICON

14 Smith & Nephew Plc Company Profile

14.1 Company Overview

14.2 Business Overview

14.2.1 Advanced Wound Management

14.2.2 Endoscopy

14.2.3 Reconstruction

14.2.4 Trauma and Clinical Therapies

14.2.5 Products

14.2.6 History

14.3 Value Chain Analysis

14.3.1 Manufacturing

14.3.2 Product Development

14.3.3 Sales and Marketing

14.4 SWOT Analysis

14.4.1 Smith & Nephew Plc Strengths

14.4.2 Smith & Nephew Plc Weaknesses

14.4.3 Smith & Nephew Plc Opportunities

14.4.4 Smith & Nephew Plc Threats

14.5 Financial and Operational Review

14.6 Locations And Subsidiaries

14.7 Financial Deals Landscape

14.7.1 Smith & Nephew Endoscopy Sells Its Vascular Business To InaVein

14.7.2 Smith & Nephew Signs An Agreement With Universal Hospital Services

14.7.3 Smith & Nephew Acquires Plus Orthopedics Holding

14.7.4 Smith & Nephew And Teknimed Enter Into Distribution Agreement

14.7.5 Smith & Nephew Acquires BlueSky Medical Group

14.7.6 Smith & Nephew Enters Into An Agreement With Covalon

14.7.7 Smith & Nephew Signs An Agreement With UDL Laboratories

14.7.8 Nexa Orthopedics Signs An Agreement With Smith & Nephew

14.7.9 Smith & Nephew Acquires Osteobiologics

14.7.10 Smith & Nephew And Q-MED Enter Into Licensing Agreement

14.7.11 Smith & Nephew Completes Sale Of 50% Interest In BSN Medical To Montagu Private Equity

14.7.12 ArthroCare Enters Into Licensing Agreement With Smith & Nephew

14.7.13 Smith & Nephew Signs Licensing Agreement With Alexandria Research Technologies

14.7.14 Smith & Nephew Signs An Agreement With ORTHOsoft

14.7.15 Osteotech And Smith & Nephew Enter Into Processing And Distribution Agreement

14.7.16 Smith & Nephew Acquires VERSAJET From HydroCision

14.7.17 Smith & Nephew Terminates Acquisition Of Biomet

14.8 Recent Developments

14.8.1 Apr 02, 2008: Smith & Nephew Declares Second Interim Dividend

14.8.2 Apr 02, 2008: Smith & Nephew Reports 2007 Results

14.8.3 Mar 23, 2008: Smith & Nephew, Corin Battle To Win Over America’s Hip Generation

14.8.4 Feb 29, 2008: Smith & Nephew Appoints SVP, GM

14.8.5 Feb 20, 2008: Smith & Nephew and Synthes Settle Patent Dispute For Trochanteric Fixation nails 291

14.8.6 Oct 22, 2007: Smith & Nephew Declares Interim Dividend

14.8.7 May 03, 2007: Smith & Nephew Appoints New CEO

14.9 Smith & Nephew Plc Pipeline Products

14.9.1 R3 Modular resurfacing Acetabular system

14.9.1.1 Product Overview

14.9.1.2 Product Description

14.9.1.3 Product Status

14.9.2 R3 Ceramic-on-ceramic Acetabular System

14.9.2.1 Product Overview

14.9.2.2 Product Description

14.9.2.3 Product Status

15 Regulation System

15.1 Medical Equipment Approval Process

15.1.1 Pre-market Approval Process

15.1.2 Intended use and Indications for use

15.1.3 Predicate Device

15.1.4 Safe and Effective

15.1.5 Other Category Devices

15.1.6 Post-Market Approval Process

15.1.7 Compliance and Enforcement

15.1.8 Registration Fee

15.1.9 Approval Time

16 Pricing and Reimbursement

16.1 Government Policies

16.2 Private Insurance

16.3 Diagnosis Related Groups (DRG)

17 Distribution Structure

17.1 Distribution Structure

18 APPENDIX

18.1 Methodology

18.2 Currency Conversion

18.3 Contact Us

18.4 Disclaimer

1.1 List of Tables

Table 1: United States Healthcare Expenditure, 2003-2010

Table 2: United States Healthcare Expenditure by Age (per person), 2000-2003

Table 3: United States Healthcare Expenditure by Sex (per person), 2000-2003

Table 4: United States Healthcare Expenditure by Race (per person), 2000-2003

Table 5: United States Personal Healthcare Expenditure by Type, 2000-2004

Table 6: United States Personal Healthcare Expenditure by Source, 2000-2004

Table 7: Total Number of Doctors in the United States, 2003-2010

Table 8: Number of Doctors by Specialty in the United States, 2003-2010

Table 9: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004

Table 10: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 (Cont.)

Table 11: Total Hospitals in the United States, 2000-2004

Table 12: Community Hospitals by Number of Beds in the United States, 2000-2004

Table 13: Number of Hospital Beds in the United States, 2000-2004

Table 14: Number of Hospital Beds by Range in the United States, 2000-2004

Table 15: Wound Care Management, United States, Overall Revenues ($ mn), 2000-2012

Table 16: Wound Care Management, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 17: Wound Care Management, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 18: Wound Care Management, United States, Category Revenues ($ mn), 2000-2012

Table 19: Wound Care Management, United States, Category Revenues ($ mn), Historic, 2000-2007

Table 20: Wound Care Management, United States, Category Revenues ($ mn), Forecast, 2007-2012

Table 21: Wound Care Management, United States, Category Volume (Units), 2000-2012

Table 22: Wound Care Management, United States, Category Volume (Units), Historic, 2000-2007

Table 23: Wound Care Management, United States, Category Volume (Units), Forecast, 2007-2012

Table 24: Wound Care Management, United States, Overall Company Share by Revenue ($ mn), 2005-2006

Table 25: Wound Closure Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 26: Wound Closure Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 27: Wound Closure Devices, United States, Revenue by Segment ($ mn), Historic, 2000-2007

Table 28: Wound Closure Devices, United States, Revenue by Segment ($ mn), Forecast, 2007-2012

Table 29: Skin Closure Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 30: Skin Closure Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 31: Hemostats, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 32: Hemostats, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 33: Tissue Sealants, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 34: Tissue Sealants, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 35: Wound Closure Devices, United States, Overall Volume (Units), Historic, 2000-2007

Table 36: Wound Closure Devices, United States, Overall Volume (Units), Forecast, 2007-2012

Table 37: Skin Closure Devices, United States, Overall Volume (Units), Historic, 2000-2007

Table 38: Skin Closure Devices, United States, Overall Volume (Units), Forecast, 2007-2012

Table 39: Hemostats, United States, Overall Volume (Units), Historic, 2000-2007

Table 40: Hemostats, United States, Overall Volume (Units), Forecast, 2007-2012

Table 41: Tissue Sealants, United States, Overall Volume (Units), Historic, 2000-2007

Table 42: Tissue Sealants, United States, Overall Volume (Units), Forecast, 2007-2012

Table 43: Hemostats, United States, Average Price ($), Historic, 2000-2007

Table 44: Hemostats, United States, Average Price ($), Forecast, 2007-2012

Table 45: Tissue Sealants, United States, Average Price ($), Historic, 2000-2007

Table 46: Tissue Sealants, United States, Average Price ($), Forecast, 2007-2012

Table 47: Skin Closure Devices, United States, Average Price ($), Historic, 2000-2007

Table 48: Skin Closure Devices, United States, Average Price ($), Forecast, 2007-2012

Table 49: Wound Closure Devices, United States, Distribution Share by Revenue ($ mn), 2005-2006

Table 50: Wound Closure Devices, United States, Company Share by Revenue ($ mn), 2005-2006

Table 51: Ostomy, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 52: Ostomy, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 53: Ostomy, United States, Overall Volume (Units), Historic, 2000-2007

Table 54: Ostomy, United States, Overall Volume (Units), Forecast, 2007-2012

Table 55: Ostomy, United States, Average Price ($), Historic, 2000-2007

Table 56: Ostomy, United States, Average Price ($), Forecast, 2007-2012

Table 57: Ostomy, United States, Distribution Share by Revenue ($ mn), 2005-2006

Table 58: Ostomy, United States, Company Share by Revenue ($ mn), 2005-2006

Table 59: Advanced Wound Management, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 60: Advanced Wound Management, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 61: Advanced Wound Management, United States, Overall Volume (Units), Historic, 2000-2007

Table 62: Advanced Wound Management, United States, Overall Volume (Units), Forecast, 2007-2012

Table 63: Advanced Wound Management, United States, Average Price ($), Historic, 2000-2007

Table 64: Advanced Wound Management, United States, Average Price ($), Forecast, 2007-2012

Table 65: Advanced Wound Management, United States, Distribution Share by Revenue ($ mn), 2005-2006

Table 66: Advanced Wound Management, United States, Company Share by Revenue ($ mn), 2005-2006

Table 67: Traditional Wound Management, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 68: Traditional Wound Management, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 69: Traditional Wound Management, United States, Overall Volume (Units), Historic, 2000-2007

Table 70: Traditional Wound Management, United States, Overall Volume (Units), Forecast, 2007-2012

Table 71: Traditional Wound Management, United States, Average Price ($), Historic, 2000-2007

Table 72: Traditional Wound Management, United States, Average Price ($), Forecast, 2007-2012

Table 73: Traditional Wound Management, United States, Distribution Share by Revenue ($ mn), 2005-2006

Table 74: Traditional Wound Management, United States, Company Share by Revenue ($ mn), 2005-2006

Table 75: Compression Therapy, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 76: Compression Therapy, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 77: Compression Therapy, United States, Overall Volume (Units), Historic, 2000-2007

Table 78: Compression Therapy, United States, Overall Volume (Units), Forecast, 2007-2012

Table 79: Compression Therapy, United States, Average Price ($), Historic, 2000-2007

Table 80: Compression Therapy, United States, Average Price ($), Forecast, 2007-2012

Table 81: Compression Therapy, Distribution Share by Revenue ($ mn), 2005-2006

Table 82: Compression Therapy, United States, Company Share by Revenue ($ mn), 2005-2006

Table 83: Baxter International Inc., SWOT Analysis, 2006

Table 84: Baxter International Inc., Financial Statements, USD Million, 2002-2006

Table 85: Baxter International Inc., Financial Ratios, USD Million, 2002-2006

Table 86: Baxter International Inc., Other Locations

Table 87: Baxter International Inc., Subsidiaries

Table 88: Covidien Ltd./Tyco Healthcare, SWOT Analysis, 2007

Table 89: Covidien Ltd./Tyco Healthcare, Financial Statements, USD Million, 2003-2007

Table 90: Covidien Ltd./Tyco Healthcare, Financial Ratios, USD Million, 2003-2007

Table 91: Covidien Ltd./Tyco Healthcare, Other Locations

Table 92: Covidien Ltd./Tyco Healthcare, Subsidiaries

Table 93: 3M Company, SWOT Analysis, 2006

Table 94: 3M Company, Financial Statements, USD Million, 2002-2006

Table 95: 3M Company, Financial and Operational Overview, USD Million, 2002-2006

Table 96: 3M Company, Subsidiaries

Table 97: Ethicon, Inc., Other Locations

Table 98: Ethicon, Inc., Subsidiaries

Table 99: Smith & Nephew Plc, SWOT Analysis, 2006

Table 100: Smith & Nephew Plc, Financial Statements, USD Million, 2002-2006

Table 101: Smith & Nephew Plc, Financial Ratios, USD Million, 2002-2006

Table 102: Smith & Nephew Plc, Other Locations

Table 103: Medical Equipment Registration Fee in United States, 2007

Table 104: Medical Device Approval Time in United States, 2004

Table 105: Currency Conversion to USD at 2006 Constant Rate

1.2 List of Figures

Figure 1: United States, Healthcare Expenditure by Source, 2003

Figure 2: United States, Healthcare Infrastructure, Top Level View, 2007

Figure 3: Healthcare Expenses Segmentation by End User, 2003

Figure 4: Wound Care Management, United States, Overall Revenues ($ mn), 2000-2012

Figure 5: Wound Care Management, United States, Overall Revenues ($ mn), Historic, 2000-2007

Figure 6: Wound Care Management, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 7: Wound Care Management, United States, Category Revenues ($ mn), 2000-2012

Figure 8: Wound Care Management, United States, Category Revenues ($ mn), Historic, 2000-2007

Figure 9: Wound Care Management, United States, Category Revenues ($ mn), Forecast, 2007-2012

Figure 10: Wound Care Management, United States, Category Volume (Units), 2000-2012

Figure 11: Wound Care Management, United States, Category Volume (Units), Historic, 2000-2007

Figure 12: Wound Care Management, United States, Category Volume (Units), Forecast, 2007-2012

Figure 13: Wound Care Management, United States, Overall Company Share (%), 2006

Figure 14: Wound Closure Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007

Figure 15: Wound Closure Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 16: Wound Closure Devices, United States, Revenue by Segment ($ mn), Historic, 2000-2007

Figure 17: Wound Closure Devices, United States, Revenue by Segment ($ mn), Forecast, 2007-2012

Figure 18: Skin Closure Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007

Figure 19: Skin Closure Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 20: Hemostats, United States, Overall Revenues ($ mn), Historic, 2000-2007

Figure 21: Hemostats, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 22: Tissue Sealants, United States, Overall Revenues ($ mn), Historic, 2000-2007

Figure 23: Tissue Sealants, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 24: Wound Closure Devices, United States, Overall Volume (Units), Historic, 2000-2007

Figure 25: Wound Closure Devices, United States, Overall Volume (Units), Forecast, 2007-2012

Figure 26: Skin Closure Devices, United States, Overall Volume (Units), Historic, 2000-2007

Figure 27: Skin Closure Devices, United States, Overall Volume (Units), Forecast, 2007-2012

Figure 28: Hemostats, United States, Overall Volume (Units), Historic, 2000-2007

Figure 29: Hemostats, United States, Overall Volume (Units), Forecast, 2007-2012

Figure 30: Tissue Sealants, United States, Overall Volume (Units), Historic, 2000-2007

Figure 31: Tissue Sealants, United States, Overall Volume (Units), Forecast, 2007-2012

Figure 32: Hemostats, United States, Average Price ($), Historic, 2000-2007

Figure 33: Hemostats, United States, Average Price ($), Forecast, 2007-2012

Figure 34: Tissue Sealants, United States, Average Price ($), Historic, 2000-2007

Figure 35: Tissue Sealants, United States, Average Price ($), Forecast, 2007-2012

Figure 36: Skin Closure Devices, United States, Average Price ($), Historic, 2000-2007

Figure 37: Skin Closure Devices, United States, Average Price ($), Forecast, 2007-2012

Figure 38: Wound Closure Devices, United States, Distribution Share (%), 2006

Figure 39: Wound Closure Devices, United States, Company Share (%), 2006

Figure 40: Ostomy, United States, Overall Revenues ($ mn), Historic, 2000-2007

Figure 41: Ostomy, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 42: Ostomy, United States, Overall Volume (Units), Historic, 2000-2007

Figure 43: Ostomy, United States, Overall Volume (Units), Forecast, 2007-2012

Figure 44: Ostomy, United States, Average Price ($), Historic, 2000-2007

Figure 45: Ostomy, United States, Average Price ($), Forecast, 2007-2012

Figure 46: Ostomy, United States, Company Share (%), 2006

Figure 47: Advanced Wound Management, United States, Overall Revenues ($ mn), Historic, 2000-2007

Figure 48: Advanced Wound Management, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 49: Advanced Wound Management, United States, Overall Volume (Units), Historic, 2000-2007

Figure 50: Advanced Wound Management, United States, Overall Volume (Units), Forecast, 2007-2012

Figure 51: Advanced Wound Management, United States, Average Price ($), Historic, 2000-2007

Figure 52: Advanced Wound Management, United States, Average Price ($), Forecast, 2007-2012

Figure 53: Advanced Wound Management, United States, Distribution Share (%), 2006

Figure 54: Advanced Wound Management, United States, Company Share (%), 2006

Figure 55: Traditional Wound Management, United States, Overall Revenues ($ mn), Historic, 2000-2007

Figure 56: Traditional Wound Management, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 57: Traditional Wound Management, United States, Overall Volume (Units), Historic, 2000-2007

Figure 58: Traditional Wound Management, United States, Overall Volume (Units), Forecast, 2007-2012

Figure 59: Traditional Wound Management, United States, Average Price ($), Historic, 2000-2007

Figure 60: Traditional Wound Management, United States, Average Price ($), Forecast, 2007-2012

Figure 61: Traditional Wound Management, United States, Distribution Share (%), 2006

Figure 62: Traditional Wound Management, United States, Company Share (%), 2006

Figure 63: Compression Therapy, United States, Overall Revenues ($ mn), Historic, 2000-2007

Figure 64: Compression Therapy, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 65: Compression Therapy, United States, Overall Volume (Units), Historic, 2000-2007

Figure 66: Compression Therapy, United States, Overall Volume (Units), Forecast, 2007-2012

Figure 67: Compression Therapy, United States, Average Price ($), Historic, 2000-2007

Figure 68: Compression Therapy, United States, Average Price ($), Forecast, 2007-2012

Figure 69: Compression Therapy, Distribution Share (%), 2006

Figure 70: Compression Therapy, United States, Company Share (%), 2006

Figure 71: Baxter International Inc., Value Chain Analysis

Figure 72: Covidien Ltd./Tyco Healthcare, Value Chain Analysis

Figure 73: 3M Company, Value Chain Analysis

Figure 74: Smith & Nephew Plc, Value Chain Analysis

Figure 75: Medical Equipment Approval Process in the United States, 2007

Figure 76: PMA Approval Process in the United States, 2007

Figure 77: The 510(k) Approval Process for Medical Devices in the United States, 2007

Figure 78: Reimbursement Structure in the United States, 2007

Figure 79: Distribution Structure of Medical Equipment in the United States, 2006

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.